technologynetworks

The Staying Power of Chromosomal Microarray Analysis: Innovations on the Horizon Will Future Proof Tried and True Technology

Genetic research labs are under constant pressure to increase their throughput while bringing down costs. Even though emerging new technologies can help labs expand their analysis capabilities, it’s ...
Nature

Do the data really support ordering fragile X testing as a first-tier test without clinical features?

Current guidelines recommend first-tier chromosome microarray analysis (CMA) and fragile X syndrome (FX) testing for males with isolated intellectual disabilities/learning delay (ID/LD) and autism ...
Medscape

Microarrays and DNA Sequencing Improve Prenatal Testing

Prenatal diagnosis is becoming more precise, according to 3 reports published in the December 5 issue of the New England Journal of Medicine. Chromosomal microarray (CMA) analysis is augmenting ...
Science Daily

Better genetic test for autism? Chromosomal microarray analysis picks up more abnormalities than current tests

A large study from Children's Hospital Boston and the Boston-based Autism Consortium finds that a genetic test that samples the entire genome, known as chromosomal microarray analysis, has about three ...
Labroots

Faster workflow and improved coverage for copy number analysis

Introducing the new CytoScan HD Accel microarray that significantly improves the power and speed of genome-wide copy number analysis using industry-leading Chromosomal Microarray (CMA). The highly ...